UniProt ID | MIF_HUMAN | |
---|---|---|
UniProt AC | P14174 | |
Protein Name | Macrophage migration inhibitory factor | |
Gene Name | MIF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 115 | |
Subcellular Localization | Secreted . Cytoplasm . Does not have a cleavable signal sequence and is secreted via a specialized, non-classical pathway. Secreted by macrophages upon stimulation by bacterial lipopolysaccharide (LPS), or by M.tuberculosis antigens. | |
Protein Description | Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.. | |
Protein Sequence | MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Sulfoxidation | -----MPMFIVNTNV -----CCEEEEECCC | 3.28 | 21406390 | |
8 | Phosphorylation | MPMFIVNTNVPRASV CCEEEEECCCCCCCC | 27.05 | 29978859 | |
12 | Methylation | IVNTNVPRASVPDGF EEECCCCCCCCCCCH | 34.90 | 54557361 | |
14 | Phosphorylation | NTNVPRASVPDGFLS ECCCCCCCCCCCHHH | 35.15 | 26074081 | |
21 | Phosphorylation | SVPDGFLSELTQQLA CCCCCHHHHHHHHHH | 28.44 | 24275569 | |
37 | Phosphorylation | ATGKPPQYIAVHVVP HHCCCCCEEEEEECC | 9.16 | 21253578 | |
54 | O-linked_Glycosylation | LMAFGGSSEPCALCS HHHCCCCCCCCHHHH | 49.16 | OGP | |
60 | S-nitrosylation | SSEPCALCSLHSIGK CCCCCHHHHHHHHCC | 1.85 | 24105792 | |
74 | Methylation | KIGGAQNRSYSKLLC CCCCCCCCCHHHHHH | 25.54 | 115483259 | |
75 | Phosphorylation | IGGAQNRSYSKLLCG CCCCCCCCHHHHHHH | 41.11 | 25849741 | |
76 | Phosphorylation | GGAQNRSYSKLLCGL CCCCCCCHHHHHHHH | 13.44 | 28102081 | |
77 | Phosphorylation | GAQNRSYSKLLCGLL CCCCCCHHHHHHHHH | 20.34 | 28102081 | |
78 | Succinylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | - | |
78 | Ubiquitination | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | 21890473 | |
78 | Malonylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | 26320211 | |
78 | 2-Hydroxyisobutyrylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | - | |
78 | Phosphoglycerylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | - | |
78 | Succinylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | - | |
78 | Acetylation | AQNRSYSKLLCGLLA CCCCCHHHHHHHHHH | 36.93 | 19608861 | |
81 | Glutathionylation | RSYSKLLCGLLAERL CCHHHHHHHHHHHHH | 5.38 | 22555962 | |
81 | S-nitrosylation | RSYSKLLCGLLAERL CCHHHHHHHHHHHHH | 5.38 | 19483679 | |
81 | S-palmitoylation | RSYSKLLCGLLAERL CCHHHHHHHHHHHHH | 5.38 | 29575903 | |
81 | S-nitrosocysteine | RSYSKLLCGLLAERL CCHHHHHHHHHHHHH | 5.38 | - | |
87 | Methylation | LCGLLAERLRISPDR HHHHHHHHHCCCCCC | 24.53 | 115483275 | |
89 | Methylation | GLLAERLRISPDRVY HHHHHHHCCCCCCEE | 33.29 | 115483283 | |
91 | Phosphorylation | LAERLRISPDRVYIN HHHHHCCCCCCEEEE | 17.83 | 11069294 | |
94 | Methylation | RLRISPDRVYINYYD HHCCCCCCEEEEEEC | 26.90 | 115483267 | |
99 | Phosphorylation | PDRVYINYYDMNAAN CCCEEEEEECCCCCC | 7.41 | - | |
100 | Phosphorylation | DRVYINYYDMNAANV CCEEEEEECCCCCCC | 12.29 | - | |
112 | O-linked_Glycosylation | ANVGWNNSTFA---- CCCCCCCCCCC---- | 22.99 | 97979813 | |
113 | O-linked_Glycosylation | NVGWNNSTFA----- CCCCCCCCCC----- | 26.21 | 26280537 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MIF_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MIF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MIF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GORS2_HUMAN | GORASP2 | physical | 16189514 | |
CSN5_HUMAN | COPS5 | physical | 11089976 | |
CHIP_HUMAN | STUB1 | physical | 22271573 | |
HS90A_HUMAN | HSP90AA1 | physical | 22271573 | |
NDKA_HUMAN | NME1 | physical | 18815136 | |
P53_HUMAN | TP53 | physical | 18815136 | |
CSN5_HUMAN | COPS5 | physical | 15757663 | |
BEX3_HUMAN | NGFRAP1 | physical | 21988832 | |
MIF_HUMAN | MIF | physical | 25416956 | |
NTAQ1_HUMAN | WDYHV1 | physical | 25416956 | |
UFM1_HUMAN | UFM1 | physical | 26344197 | |
EGFR_HUMAN | EGFR | physical | 26280537 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
604302 | Rheumatoid arthritis systemic juvenile (RASJ) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-78, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-37, AND MASSSPECTROMETRY. |